6.85

0.74% 0.05

Exozymes Inc (EXOZ)

Overview News Price History Discussions Forecast

Exozymes Inc stock is traded at $6.85, with a volume of 1,304. It is up +0.74% in the last 24 hours and up +48.27% over the past month. EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.

Previous Close:

$6.80

Open:

$7.1

24h Volume:

1,304

Relative Volume:

0.14

Market Cap:

$63.58M

Revenue:

$70,100

Net Income/Loss:

$-9.67M

P/E Ratio:

-5.9508

EPS:

-1.1511

Net Cash Flow:

$-7.09M

1W Performance:

-4.43%

1M Performance:

+48.27%

6M Performance:

-3.39%

1Y Performance:

-35.22%

1-Day Range:

$6.85

$7.10

1-Week Range:

$6.45

$7.28

52-Week Range:

$4.35

$18.40

Exozymes Inc Stock (EXOZ) Company Profile

Name

Exozymes Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(626) - 415 - 1488

Address

750 ROYAL OAKS DR, MONROVIA

Employee

Twitter

Next Earnings Date

2026-08-20

Latest SEC Filings

EXOZ's Discussions on Twitter

Compare EXOZ vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EXOZ Exozymes Inc	6.85	65.34M	70,100	-9.67M	-7.09M	-1.1511
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Exozymes Inc Stock (EXOZ) Latest News

Aug 20, 2026

eXoZymes (EXOZ): Ends Up by 10.00% at $7.04; Trading Range: the Near-Term Reference Band Stretches From $6.69 to $7.39 in the Available RecordKey Reversal Day - vinanet.vn

Aug 20, 2026

eXoZymes Q2FY26 Results: Net loss widens to $2.88M, raises $6M - scanx.trade

Aug 20, 2026

eXoZymes Q2 Earnings Call Highlights - Yahoo Finance

Aug 20, 2026

Earnings call transcript: eXoZymes posts q2 2026 loss as launch plans advance - Investing.com

Aug 20, 2026

EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization - TradingView

Aug 20, 2026

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - The Batesville Daily Guard

Aug 20, 2026

Aug 18, 2026

exoZymes reports 10-fold productivity gain in NCT manufacturing By Investing.com - Investing.com Canada

Aug 18, 2026

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - ACCESS Newswire

Aug 18, 2026

EXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - marketscreener.com

Aug 18, 2026

News by ACCESS Newswire on TradingView, 2026-08-18 - TradingView

Aug 18, 2026

Aug 16, 2026

Will eXoZymes (NASDAQ:EXOZ) Spend Its Cash Wisely? - Sahm

Aug 16, 2026

Aug 15, 2026